340B Report Publisher and CEO: What Two State Legislative Sessions Tell Us About the State of 340B Policy

Red state blue state
What do the outcomes of 340B policy debates in a red state and a blue state mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky provides important analysis in his new column for Verity Solutions.

What do the outcomes of 340B policy debates in two state legislatures on opposite ends of the political spectrum mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky gives the most important takeaways in his latest column for

Read More »

Minnesota Imposes Nation’s First 340B Covered Entity Reporting Requirements

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.

Minnesota health care providers were shocked to learn that a bill signed into law in late May made their state the first to require all 340B covered entities to report their total 340B drug acquisition costs and payments.

The first

Read More »

AHA Urges HRSA to Restore Policy Allowing Earlier Use of 340B Drugs in Hospital Outpatient Clinics

AHA
The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.

The American Hospital Association has asked the U.S. Health Resources and Services Administration to resume letting hospitals dispense 340B drugs at offsite clinics that have not yet appeared on the hospital’s most recently filed Medicare cost report.

AHA asked HRSA

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live